Allium sativum is cultivated in the northern part of Ghana and has gained widespread use as chemoprotective, in curing hypertension, impotence and erectile dysfunction. The multipurpose use together with its aphrodisiac activity has resulted in the widespread use of this plant medicine both in meals and as herbal medications. Safety assessment of this plant however is rare. The present study is designed to evaluate the toxic effect of the aqueous extract of Allium sativa on the prostate, heart, liver kidney and haematological parameters after a shorterm administration in male-sprague-dawley rats. The following doses were used in different groups of male Sprague-Dawley Rats: 5000, 3000 and 1000 mg kg −1 . The following parameters were monitored: Clinical Chemistry, Gross and Histopathology (Heart, kidney, liver and prostate). No death was recorded at the highest dose of 5000 mg kg −1 . ASE reduced levels of urea and creatinine but increased levels of liver enzymes ALT, AST, ALP and bilirubin levels as compared to the controls. There was a statistically significant increase in WBC count (p<0.005) in all the doses except the median dose. There were no significant change in Red Blood Cell count (RBC) (p<0.003), Haemoglobin (HGB) (p<0.03), Haematocrit (HCT) p<0.0001), Mean Corpuscular Volume (MCV) Other parameters remained relatively unchanged. Gross pathology did not reveal any abnormality. Histopathological analysis showed that the extract did not have any adverse effect on the integrity of these organs. The results were within histopathological limits and did not reveal any abnormality in the examined organs namely: The prostate, kidney, liver and heart which maintained their integrity after the dose administration. Observations were within histopathological limits. ASE is reasonably safe when administered by the oral route within dosages of 1000-5000 mg kg −1 in Sprague dawley rats. This research has provided the safety implications as to the use of this plant.
Objective. To compare the risk of subsequent fractures after an initial traumatic or nontraumatic fracture in postmenopausal women. Design.A prospective observational study utilizing data from the Women's Health Initiative (WHI) Study, WHI Clinical Trials (WHI-CT), and WHI Bone Density Substudy to evaluate rates at which patients who suffered a traumatic fracture vs nontraumatic fracture develop a subsequent fracture.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.